Brief: Liquidia Corp United Therapeutics Filed New Cross-Claims In FDA Suit Against FDA
Sept 17 (Reuters) - Liquidia Corp LQDA.O :
* LIQUIDIA CORP: UNITED THERAPEUTICS FILED NEW CROSS-CLAIMS
IN FDA
SUIT AGAINST FDA, RE-ASSERTING CHALLENGE TO FDA'S ACCEPTANCE OF
CO'S YUTREPIA NDA
* LIQUIDIA- INTENDS TO DEFEND ITS ABILITY TO LAUNCH YUTREPIA
& TO
DEFEND ITSELF AGAINST UNITED'S ALLEGATIONS
Source text for Eikon: ID:n0001104659-24-100714
Further company coverage: LQDA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Liquidia
See all newsUS STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing